Both in Pharmaceuticals
FitLife Brands vs Acrivon Therapeutics
Over the past year FTLF returned −54.3% and ACRV returned +14.3%; their daily moves had a correlation of -0.01.
FTLF −54.3% ACRV +14.3%Growth of $1, one year, split-adjusted
| Metric | FTLF | ACRV |
|---|---|---|
| Price | $9.09 | $2.08 |
| Market cap | $85.4M | $89.1M |
| Today | −2.15% | +0.97% |
| 1 month | −7.1% | +1.0% |
| 6 months | −36.3% | +61.2% |
| Year to date | −44.1% | −13.7% |
| 1 year | −54.3% | +25.3% |
| Revenue growth (YoY) | +64.6% | — |
| Gross margin | 37.0% | — |
| Net margin | 7.3% | — |
| P/E (TTM) | 13.7× | — |
| Price / sales | 0.8× | — |
| Net cash | -$36.8M | $90.0M |
| Dividend yield | — | — |
| Volatility (60d) | 44.3% | 77.7% |
| Short % of float | 2.2% | 5.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).